News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
708,382 Results
Type
Article (40686)
Company Profile (297)
Press Release (667399)
Multimedia
Podcasts (75)
Webinars (12)
Section
Business (207091)
Career Advice (2073)
Deals (35877)
Drug Delivery (100)
Drug Development (82390)
Employer Resources (176)
FDA (16258)
Job Trends (15175)
News (350126)
Policy (32873)
Tag
Academia (2574)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50237)
ALS (90)
Alzheimer's disease (1403)
Antibody-drug conjugate (ADC) (131)
Approvals (16259)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (16)
Bankruptcy (363)
Best Places to Work (11758)
BIOSECURE Act (21)
Biosimilars (108)
Biotechnology (212)
Bladder cancer (78)
Brain cancer (28)
Breast cancer (281)
Cancer (2267)
Cardiovascular disease (178)
Career advice (1730)
Career pathing (33)
CAR-T (151)
Cell therapy (428)
Cervical cancer (19)
Clinical research (67034)
Collaboration (846)
Compensation (531)
Complete response letters (21)
COVID-19 (2613)
CRISPR (40)
C-suite (246)
Cystic fibrosis (101)
Data (2213)
Decentralized trials (2)
Denatured (26)
Depression (46)
Diabetes (271)
Diagnostics (6387)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (120)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (95)
Earnings (87643)
Editorial (42)
Employer branding (23)
Employer resources (150)
Events (114821)
Executive appointments (737)
FDA (17512)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (749)
Gene editing (106)
Generative AI (20)
Gene therapy (307)
GLP-1 (737)
Government (4462)
Grass and pollen (5)
Guidances (59)
Healthcare (18899)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (30)
Infectious disease (2755)
Inflammatory bowel disease (138)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (97)
Interviews (328)
IPO (16745)
IRA (41)
Job creations (3839)
Job search strategy (1470)
Kidney cancer (10)
Labor market (38)
Layoffs (483)
Leadership (22)
Legal (7960)
Liver cancer (75)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (308)
MASH (70)
Medical device (13392)
Medtech (13397)
Mergers & acquisitions (19681)
Metabolic disorders (698)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (29)
Neuroscience (1948)
NextGen: Class of 2025 (6572)
Non-profit (4500)
Now hiring (40)
Obesity (371)
Opinion (223)
Ovarian cancer (76)
Pain (86)
Pancreatic cancer (83)
Parkinson's disease (150)
Partnered (21)
Patents (235)
Patient recruitment (111)
Peanut (46)
People (58157)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20920)
Phase II (29578)
Phase III (21921)
Pipeline (1192)
Policy (149)
Postmarket research (2573)
Preclinical (8888)
Press Release (64)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (256)
Rare diseases (380)
Real estate (6032)
Recruiting (67)
Regulatory (22535)
Reports (46)
Research institute (2343)
Resumes & cover letters (354)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (31)
Startups (3659)
State (2)
Stomach cancer (13)
Supply chain (70)
Tariffs (42)
The Weekly (47)
Vaccines (702)
Venture capitalists (42)
Weight loss (243)
Women's health (38)
Worklife (20)
Date
Today (174)
Last 7 days (875)
Last 30 days (2661)
Last 365 days (33253)
2025 (10747)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56341)
2020 (54536)
2019 (46982)
2018 (35391)
2017 (32636)
2016 (32065)
2015 (38116)
2014 (32009)
2013 (26901)
2012 (29018)
2011 (29672)
2010 (27710)
Location
Africa (742)
Alabama (58)
Alaska (7)
Arizona (233)
Arkansas (14)
Asia (39143)
Australia (6330)
California (6144)
Canada (2016)
China (539)
Colorado (269)
Connecticut (275)
Delaware (148)
Europe (84511)
Florida (919)
Georgia (205)
Idaho (57)
Illinois (538)
India (25)
Indiana (309)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (902)
Massachusetts (4616)
Michigan (219)
Minnesota (393)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1739)
New Mexico (29)
New York (1749)
North Carolina (1020)
North Dakota (8)
Northern California (2678)
Ohio (204)
Oklahoma (14)
Oregon (35)
Pennsylvania (1376)
Puerto Rico (13)
Rhode Island (33)
South America (1122)
South Carolina (22)
South Dakota (1)
Southern California (2305)
Tennessee (101)
Texas (913)
United States (23292)
Utah (181)
Virginia (147)
Washington D.C. (62)
Washington State (561)
West Virginia (3)
Wisconsin (54)
708,382 Results for "sunshine biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
April 4, 2025
·
4 min read
Press Releases
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
April 3, 2025
·
4 min read
Press Releases
Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
April 3, 2025
·
3 min read
Press Releases
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
April 21, 2025
·
3 min read
Press Releases
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
April 2, 2025
·
3 min read
Press Releases
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
March 10, 2025
·
3 min read
Press Releases
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada
March 25, 2025
·
3 min read
Press Releases
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
January 15, 2025
·
4 min read
Business
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Sunshine Biopharma, Inc. today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission.
May 21, 2024
·
3 min read
Deals
Sunshine Biopharma Announces Reverse Stock Split
Sunshine Biopharma, Inc. announced today a one for one hundred reverse split of its common stock, effective at market open on April 17, 2024.
April 12, 2024
·
2 min read
1 of 70,839
Next
